Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Gabapentin for Radiation Therapy Induced Pain in Oropharyngeal Cancer
NCT03269344Phase 3Completed
- Sponsor
- Henry Ford Health
- Start
- Jun 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin in pain, mucositis, sponsored by Henry Ford Health. Started Jun 2017; status: completed.
02
Drugs
gabapentin
03
Conditions
painmucositis
Beyond the preview
Go deeper on NCT03269344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269344.